Generally Accepted Accounting Practice

Conformis Reports Second Quarter 2021 Financial Results

Retrieved on: 
Wednesday, August 4, 2021

Conformis Hip System revenue of $0.9 million for the second quarter of 2021 was up 62% year-over-year and increased 38% from the first quarter of 2021.

Key Points: 
  • Conformis Hip System revenue of $0.9 million for the second quarter of 2021 was up 62% year-over-year and increased 38% from the first quarter of 2021.
  • Product Revenue compared to the second quarter of 2019 was down 21%, a sequential improvement from the 33% decline in the first quarter.
  • Total gross profit increased $36.5 million to $47.5 million, or 84% of revenue, in the second quarter of 2021, compared to $11.0 million, or 57% of revenue, in the second quarter of 2020.
  • In addition to disclosing financial measures prepared in accordance with U.S. generally accepted accounting principles (GAAP), the Company provides certain information regarding the Company's financial results or projected financial results on a non-GAAP "constant currency basis."

Option Care Health Announces Financial Results for the Second Quarter Ended June 30, 2021

Retrieved on: 
Tuesday, August 3, 2021

Our actual results and financial condition may differ materially from those indicated in the forward-looking statements.

Key Points: 
  • Our actual results and financial condition may differ materially from those indicated in the forward-looking statements.
  • In addition to reporting financial information in accordance with generally accepted accounting principles (GAAP), the Company is also reporting Adjusted EBITDA, which is a non-GAAP financial measure.
  • Management believes that Adjusted EBITDA provides useful supplemental information regarding the performance of Option Care Healths business operations and facilitates comparisons to the Companys historical operating results.
  • For a full reconciliation of Adjusted EBITDA to the most comparable GAAP financial measure, please see the attachment to this earnings release.

Gartner Reports Second Quarter 2021 Financial Results

Retrieved on: 
Tuesday, August 3, 2021

Certain financial metrics contained in this Press Release are considered non-GAAP financial measures.

Key Points: 
  • Certain financial metrics contained in this Press Release are considered non-GAAP financial measures.
  • Definitions of these non-GAAP financial measures are included in this Press Release under Non-GAAP Financial Measures and the related reconciliations are under Supplemental Information Non-GAAP Reconciliations.
  • Gartner, Inc. (NYSE: IT) is the worlds leading research and advisory company and a member of the S&P 500.
  • Certain financial measures used in this Press Release are not defined by U.S. generally accepted accounting principles (GAAP) and as such are considered non-GAAP financial measures.

Spire Global, Inc. Announces Preliminary First Half 2021 Selected Financial Results, Provides Updated Guidance for 2021

Retrieved on: 
Thursday, July 29, 2021

The selected, estimated preliminary financial results set forth are unaudited and should be considered preliminary and subject to change.

Key Points: 
  • The selected, estimated preliminary financial results set forth are unaudited and should be considered preliminary and subject to change.
  • Accordingly, you should not place undue reliance on this preliminary data, which may differ materially from the final results.
  • These preliminary results should not be viewed as a substitute for Spires full financial statements for the six months ended June 30, 2021 prepared in accordance with U.S. generally accepted accounting principles (GAAP).
  • This preliminary financial data included in this announcement has been prepared by, and is the responsibility of, Spire's management.

Financial information in the Form S-1 registration statement and Change to Board of Directors

Retrieved on: 
Monday, July 12, 2021

The registration statement included a proposed change to the board of directors as well as unaudited financial information which is detailed below.

Key Points: 
  • The registration statement included a proposed change to the board of directors as well as unaudited financial information which is detailed below.
  • The Company's Form S-1 registration statement contains unaudited consolidated financial statements for the period from 1 January 2021 to 31 March 2021 prepared in accordance with generally accepted accounting principles in the United States ("U.S. GAAP").
  • Such consolidated financial statements, as extracted from the Form S-1 registration statement, are attached to this announcement.
  • In line with Nasdaq best practices to not have the CFO nor CAO on a Company's board, Mr. Holtz has resigned from our board of directors.

Dycom Industries, Inc. Announces Fiscal 2022 First Quarter Results

Retrieved on: 
Tuesday, May 25, 2021

The Company reports its financial results in accordance with U.S. generally accepted accounting principles (GAAP).

Key Points: 
  • The Company reports its financial results in accordance with U.S. generally accepted accounting principles (GAAP).
  • The Company cautions that Non-GAAP financial measures should be considered in addition to, but not as a substitute for, the Company's reported GAAP results.
  • Excluding these amounts from the Company's Non-GAAP financial measures provides management with a more consistent measure for assessing financial results.
  • The Company excludes this impact because the Company believes it is not indicative of the Company's underlying results or ongoing operations.

Recro Reports First Quarter 2021 Financial Results

Retrieved on: 
Thursday, May 6, 2021

During the first quarter, Recro announced the signing of a second amendment to its existing credit facility with Athyrium Capital Management.

Key Points: 
  • During the first quarter, Recro announced the signing of a second amendment to its existing credit facility with Athyrium Capital Management.
  • Experience shows that a new business development organization, as there is at Recro, usually takes multiple quarters to optimize performance.
  • The company cautions against extrapolating quarterly results to estimate full year results.\nTo supplement our financial results determined by U.S. generally accepted accounting principles (\xe2\x80\x9cGAAP\xe2\x80\x9d), we have certain non-GAAP information for our business, including EBITDA, as adjusted.
  • Non-GAAP financial measures should be considered in addition to, but not as a substitute for, reported GAAP results.

ICU Medical, Inc. Announces First Quarter 2021 Results

Retrieved on: 
Thursday, May 6, 2021

b'This press release contains financial measures that are not calculated in accordance with U.S. generally accepted accounting principles ("GAAP").

Key Points: 
  • b'This press release contains financial measures that are not calculated in accordance with U.S. generally accepted accounting principles ("GAAP").
  • The non-GAAP financial measures should be considered supplemental to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP.
  • Our management believes that the non-GAAP data provides useful supplemental information to management and investors regarding our performance and facilitates a more meaningful comparison of results of operations between current and prior periods.
  • The value of stock options is determined using a complex formula that incorporates factors, such as market volatility, that are beyond our control.

Conformis Reports First Quarter 2021 Financial Results

Retrieved on: 
Wednesday, May 5, 2021

Net proceeds were approximately $79.6 million.\nWe expect our second quarter product revenue to improve sequentially from the first quarter and to be in the range of $14.0 million to $14.5 million.\nWe believe elective procedure volumes will improve in the third quarter and approach 2019 levels in the fourth quarter as vaccines become more widely available.\nIn addition to disclosing financial measures prepared in accordance with U.S. generally accepted accounting principles (GAAP), the Company provides certain information regarding the Company\'s financial results or projected financial results on a non-GAAP "constant currency basis."

Key Points: 
  • Net proceeds were approximately $79.6 million.\nWe expect our second quarter product revenue to improve sequentially from the first quarter and to be in the range of $14.0 million to $14.5 million.\nWe believe elective procedure volumes will improve in the third quarter and approach 2019 levels in the fourth quarter as vaccines become more widely available.\nIn addition to disclosing financial measures prepared in accordance with U.S. generally accepted accounting principles (GAAP), the Company provides certain information regarding the Company\'s financial results or projected financial results on a non-GAAP "constant currency basis."
  • This information estimates the impact of changes in foreign currency rates on the translation of the Company\'s current or projected future period financial results as compared to the applicable comparable period.
  • It does not include any other effect of changes in foreign currency rates on the Company\'s results or business.
  • Company management uses these non-GAAP measures internally to measure operational performance.\nAs previously announced, Conformis will conduct a webcast today at 4:30 PM Eastern Time.

Akoustis Reports Record Third Quarter Fiscal 2021 Revenue

Retrieved on: 
Monday, May 3, 2021

b'We regularly review a number of metrics, including Non-GAAP Operating Loss and Non-GAAP Net Loss, which are not financial measures calculated in accordance with generally accepted accounting principles in the United States (\xe2\x80\x9cGAAP\xe2\x80\x9d).

Key Points: 
  • b'We regularly review a number of metrics, including Non-GAAP Operating Loss and Non-GAAP Net Loss, which are not financial measures calculated in accordance with generally accepted accounting principles in the United States (\xe2\x80\x9cGAAP\xe2\x80\x9d).
  • The Company utilizes its proprietary XBAW\xc2\xae manufacturing process to produce bulk acoustic wave RF filters for\xc2\xa0mobile and other wireless\xc2\xa0markets, which facilitate signal acquisition and accelerate band performance between the antenna and digital back end.
  • The Company owns and operates a\xc2\xa0120,000 sq.
  • Forward-looking statements are neither historical facts nor assurances of future results, performance, events or circumstances.